Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 20;33(33):e122-4.
doi: 10.1200/JCO.2013.51.1683. Epub 2014 Apr 28.

Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma

Douglas B Johnson  1 , Vita Saranga-Perry  2 , Patrick J M Lavin  3 , W Bryan Burnette  3 , Stephen W Clark  3 , David R Uskavitch  3 , Deborah E Wallace  3 , Mark A Dickson  4 , Ragini R Kudchadkar  2 , Jeffrey A Sosman  3
Affiliations

Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma

Douglas B Johnson et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

References

    1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. - PubMed
    1. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507–2516. - PMC - PubMed
    1. Sosman JA, Kim KB, Schuchter L, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med. 2012;366:707–714. - PMC - PubMed
    1. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711–723. - PMC - PubMed
    1. Selby MJ, Engelhardt JJ, Quigley M, et al. Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells. Cancer Immunol Res. 2013;1:32–42. - PubMed

MeSH terms